We are live on ! Find out more
DWA

Dorsey Wright & Associates Portfolio holdings

AUM $590M
1-Year Est. Return 77.57%
This Fund
S&P 500
This Quarter Est. Return
+16.38%
1 Year Est. Return
+77.57%
3 Year Est. Return
+310.64%
5 Year Est. Return
10 Year Est. Return
AUM
$414M
AUM Growth
+$79.2M
Cap. Flow
+$38M
Cap. Flow %
9.19%
Top 10 Hldgs %
17.26%
Holding
356
New
91
Increased
48
Reduced
145
Closed
70

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$8.84M
2
BA icon
Boeing
BA
+$7.79M
3
EC icon
Ecopetrol
EC
+$4.96M
4
HAE icon
Haemonetics
HAE
+$4.3M
5
RPM icon
RPM International
RPM
+$3.92M

Sector Composition

Rank Sector Weight
1 Technology 17.43%
2 Healthcare 14.46%
3 Consumer Discretionary 8.06%
4 Industrials 6.76%
5 Materials 6.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NSTG
151
DELISTED
NanoString Technologies, Inc.
NSTG
$14K ﹤0.01%
567
-564
-50% -$13K
AUDC icon
152
AudioCodes
AUDC
$253M
$13K ﹤0.01%
926
-924
-50% -$12.2K
LAB icon
153
Standard BioTools
LAB
$294M
$13K ﹤0.01%
968
-966
-50% -$10.2K
MSB
154
Mesabi Trust
MSB
$305M
$13K ﹤0.01%
447
-447
-50% -$12.8K
TPB icon
155
Turning Point Brands
TPB
$1.73B
$13K ﹤0.01%
279
-279
-50% -$10.7K
KALV
156
DELISTED
KalVista Pharmaceuticals
KALV
$12K ﹤0.01%
433
-429
-50% -$9.3K
OFG icon
157
OFG Bancorp
OFG
$2.26B
$12K ﹤0.01%
621
-621
-50% -$12K
RARX
158
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
$12K ﹤0.01%
542
-537
-50% -$11.5K
REGI
159
DELISTED
Renewable Energy Group, Inc.
REGI
$12K ﹤0.01%
543
-543
-50% -$14K
ATTU
160
DELISTED
Attunity Ltd
ATTU
$12K ﹤0.01%
524
-522
-50% -$11.6K
AVTX icon
161
Avalo Therapeutics
AVTX
$1.04B
$11K ﹤0.01%
1
AXSM icon
162
Axsome Therapeutics
AXSM
$11.2B
$11K ﹤0.01%
+793
New +$7.36K
KRYS icon
163
Krystal Biotech
KRYS
$9.72B
$11K ﹤0.01%
343
-342
-50% -$8.06K
LFVN icon
164
LifeVantage
LFVN
$81.9M
$11K ﹤0.01%
754
-750
-50% -$10.9K
MLAB icon
165
Mesa Laboratories
MLAB
$633M
$11K ﹤0.01%
46
-45
-49% -$10.2K
QTNT
166
DELISTED
Quotient Limited Ordinary Shares
QTNT
$11K ﹤0.01%
30
-30
-50% -$10.6K
SHSP
167
DELISTED
SharpSpring, Inc.
SHSP
$11K ﹤0.01%
714
-711
-50% -$10.2K
OSIR
168
DELISTED
Osiris Therapeutics, Inc. Common Stock
OSIR
$11K ﹤0.01%
597
-597
-50% -$9.68K
ABR icon
169
Arbor Realty Trust
ABR
$981M
$10K ﹤0.01%
800
-760
-49% -$9.23K
ADUS icon
170
Addus HomeCare
ADUS
$2.2B
$10K ﹤0.01%
159
-159
-50% -$10.2K
AMRC icon
171
Ameresco
AMRC
$1.47B
$10K ﹤0.01%
642
-642
-50% -$10.1K
CHEF icon
172
Chefs' Warehouse
CHEF
$4.57B
$10K ﹤0.01%
315
-315
-50% -$10.3K
CLAR icon
173
Clarus
CLAR
$145M
$10K ﹤0.01%
783
-784
-50% -$8.84K
DCO icon
174
Ducommun
DCO
$3.01B
$10K ﹤0.01%
228
-228
-50% -$9.36K
ENPH icon
175
Enphase Energy
ENPH
$5.39B
$10K ﹤0.01%
+1,116
New +$8.49K

Similar funds

Dorsey Wright & Associates's Q1 2019 Portfolio in Review

As of Q1 2019, Dorsey Wright & Associates held 356 positions worth $414M, up 24% from $334M the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Dorsey Wright & Associates deployed $38M of net new capital in Q1 2019, opening 91 new positions and adding to 48 existing holdings. Its largest new stake was Zebra Technologies: 33,077 shares worth $6.93M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Boeing, an estimated $7.79M trimmed.

  • Dorsey Wright & Associates's largest Q1 2019 buy was Zebra Technologies: 33,077 shares worth $6.93M.
  • Dorsey Wright & Associates added most to Rollins in Q1 2019, an estimated $2.98M increase.
  • Dorsey Wright & Associates's biggest Q1 2019 reduction was Boeing, cutting an estimated $7.79M.
  • Dorsey Wright & Associates fully exited State Street SPDR S&P 500 ETF Trust in Q1 2019, selling an estimated $8.84M.
  • Dorsey Wright & Associates's ten largest holdings make up 17% of its $414M portfolio in Q1 2019.
  • Dorsey Wright & Associates opened 91 new positions and closed 70 in Q1 2019.
  • Dorsey Wright & Associates's portfolio value rose 24% quarter-over-quarter to $414M.

Based on Dorsey Wright & Associates's 13F filing for Q1 2019, filed 4 Apr 2019.